X-14845014-A-G
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001018113.3(FANCB):c.1769T>C(p.Phe590Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0015 in 1,208,655 control chromosomes in the GnomAD database, including 5 homozygotes. There are 649 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001018113.3 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group BInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- VACTERL association, X-linked, with or without hydrocephalusInheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- VACTERL with hydrocephalusInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FANCB | NM_001018113.3 | c.1769T>C | p.Phe590Ser | missense_variant | Exon 8 of 10 | ENST00000650831.1 | NP_001018123.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00111 AC: 124AN: 112170Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.00158 AC: 289AN: 182657 AF XY: 0.00183 show subpopulations
GnomAD4 exome AF: 0.00154 AC: 1684AN: 1096433Hom.: 5 Cov.: 30 AF XY: 0.00168 AC XY: 609AN XY: 361935 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00110 AC: 124AN: 112222Hom.: 0 Cov.: 23 AF XY: 0.00116 AC XY: 40AN XY: 34408 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
- -
not specified Benign:2
- -
- -
Fanconi anemia complementation group B Benign:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
- -
History of neurodevelopmental disorder Uncertain:1
Co-segregation data for this variant is currently unavailable.This variant has not been detected in conjunction with a pathogenic mutation to date.Based on data from the NHLBI Exome Sequencing Project (ESP), the C-allele was absent in 1997 male alleles studied and was not observed in the homozygous state in 3382 female alleles studied (http://browser.1000genomes.org Released July 2010). This amino acid position is not conserved on limited sequence alignment.This alteration is predicted to be possibly damaging with a score of 0.605 (sensitivity: 0.80; specificity: 0.82)This alteration is predicted to be tolerated with a score of 0.140 (conservation: 2.54) -
Fanconi anemia Benign:1
- -
FANCB-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Fanconi anemia complementation group A Benign:1
- -
VACTERL association, X-linked, with or without hydrocephalus Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Malignant tumor of breast Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at